Phenobarbital Infusion for Refractory Seizures
For refractory status epilepticus not controlled by benzodiazepines and second-line agents, administer phenobarbital IV at a loading dose of 10-20 mg/kg over 10-15 minutes, with the option to repeat 5-10 mg/kg boluses every 10 minutes if seizures persist. 1, 2
Dosing Protocol
Loading Dose
- Initial dose: 10-20 mg/kg IV over 10-15 minutes 1, 3, 2
- Pediatric dose: 15-20 mg/kg IV over 10-15 minutes 3
- Maximum infusion rate: 60 mg/min in adults (do not exceed 1 mg/kg/min in children) 2, 3
- Repeat dosing: If seizures persist, administer additional 5-10 mg/kg boluses every 10 minutes 1, 2
- Maximum total dose: Up to 30-40 mg/kg may be required 4
Maintenance Infusion
For refractory cases requiring continuous infusion:
- Pentobarbital (preferred barbiturate for continuous infusion): 13 mg/kg bolus, then 2-3 mg/kg/hour 1
- Phenobarbital maintenance: 1-3 mg/kg every 12 hours after loading 5
Clinical Context and Positioning
Phenobarbital has fallen out of favor as a first-line agent but remains highly effective for refractory seizures. In the only Class I study (Veterans Affairs cooperative trial), phenobarbital terminated seizures 58.2% of the time as initial medication 1. More recent data shows pentobarbital achieved 92% success in refractory status epilepticus, superior to propofol's 73% 1.
When to Use Phenobarbital
Use phenobarbital when:
- Seizures persist despite optimal benzodiazepine dosing AND a second-line agent (fosphenytoin, levetiracetam, or valproate) 6
- Patient is already intubated or intubation is immediately available
- Other agents have failed or are contraindicated
The 2024 ACEP guidelines recommend fosphenytoin, levetiracetam, or valproate as equivalent second-line agents after benzodiazepines 6. Phenobarbital should be considered third-line or for truly refractory cases.
Monitoring Requirements
Essential Monitoring
- Continuous cardiac monitoring with ECG 2
- Blood pressure monitoring - preferably arterial line for continuous infusion 4
- Respiratory monitoring with pulse oximetry 3, 2
- Vital signs recorded throughout administration 2
- Equipment for resuscitation and artificial ventilation must be immediately available 2
Titration Strategy
- Observe response after each bolus before administering additional doses 7
- In one study, seizures stopped within the first minute of infusion in 64% of successful cases 7
- If no response after reaching 40 mg/kg total dose, consider adding a second anticonvulsant rather than further phenobarbital escalation 8
Critical Safety Considerations
Major Adverse Effects
The main limitation is the increased adverse effects profile, particularly hypotension and respiratory depression 1. In comparative studies, barbiturates required vasopressor support in 77% of cases versus 42% with propofol 1.
Administration Precautions
- Use large veins only - avoid dorsum of hand or wrist 2
- Never administer subcutaneously 2
- Avoid varicose veins due to retarded circulation 2
- Aspirate before injection to prevent inadvertent intraarterial injection, which can cause gangrene requiring amputation 2
Respiratory Support
- Be prepared to intubate - respiratory depression is dose-dependent 1, 4, 1
- Intubation occurred in 20-26% of patients receiving second-line agents in the ESETT trial 6
- Have airway equipment immediately available before starting infusion 3, 2
Practical Clinical Pearls
Dosing Optimization
- Faster infusion rates correlate with better efficacy - one study showed higher success with more rapid administration 7
- Therapeutic plasma levels (10-40 mcg/mL) can be achieved with lower doses than expected in some patients 7
- Recent data suggests moderate doses (5-19.8 mg/kg, median 10.1 mg/kg) may be sufficient in non-comatose patients without requiring intubation 9
Drug Interactions
- No potentiation of side effects when diazepam is given after phenobarbital 7
- However, combined use with other sedatives increases apnea risk 3
Special Populations
- Ideal body weight (IBW) is the best predictor of required dose - use allometric scaling 10
- High pharmacokinetic variability in ICU patients results in only ~40% target attainment with standard dosing 10
- Gestational age <32 weeks associated with better response in neonates 8
Common Pitfalls to Avoid
Administering too slowly: The FDA label allows up to 60 mg/min in adults, but many clinicians infuse more conservatively than necessary 2
Stopping too early: If initial dose fails, additional boluses up to 30-40 mg/kg total may be needed before declaring treatment failure 4
Inadequate preparation: Failing to have intubation equipment and vasopressors immediately available before starting infusion
Wrong vein selection: Using small peripheral veins increases risk of thrombosis and extravasation 2
Overlooking oral bioavailability: Phenobarbital has 96% oral bioavailability, allowing transition to oral maintenance dosing once seizures controlled 10